India's Godavari Biorefineries at 2-month high after securing US patent for cancer treatment
15/10/2026 05:25
BUZZ-India's Godavari Biorefineries at 2-month high after securing US patent for cancer treatment ** Shares of Godavari Biorefineries GODA.NS rise as much as 14.6% to a two-month high of 262 rupees
** Stock on track for its biggest one day pct. in more than two months, if gains hold
** Co says it has been granted a patent in the US for the compound 5-hydroxy-1,4 naphthalenedione for use in the treatment of cancer
** "Patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate" - GODA
** YTD, stock down 7.4%
(Reporting by Puyaan Singh in Bengaluru)
Recent news on Godavari Biorefineries
See all newsIndia's Godavari Biorefineries at 2-month high after securing US patent for cancer treatment
Brief: Godavari Biorefineries Says US Patent Granted For Cancer Treatment Compound
Brief: Godavari Biorefineries Says Mexican Patent Office Grants Patent For Compounds Treating Viral Infections
India's Godavari Biorefineries jumps after securing Chinese patent
Brief: Godavari Biorefineries Says Chinese Patent Office Grants Patent For Use Of Compounds To Treat Viral Infections